Transitional cell carcinoma and Cognitive disorder

Summary:

Cognitive disorder is found among people with Transitional cell carcinoma, especially for people who are male, 60+ old.

The study analyzes which people have Cognitive disorder with Transitional cell carcinoma. It is created by eHealthMe based on reports of 15 people who have Transitional cell carcinoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Transitional cell carcinoma?

Transitional cell carcinoma (cancer tumour inner most layer of urinary system) is found to be associated with 191 drugs and 268 conditions by eHealthMe. Check the latest studies of Transitional cell carcinoma.

What is Cognitive disorder?

Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving) is found to be associated with 1,657 drugs and 1,727 conditions by eHealthMe. Check the latest studies of Cognitive disorder.

On Jul, 13, 2026

15 people who have Transitional Cell Carcinoma and Cognitive Disorder are studied.

Would you have Cognitive disorder when you have Transitional cell carcinoma?

Gender of people who have Transitional Cell Carcinoma and experienced Cognitive Disorder *:

female: 13.33 %
male: 86.67 %

Age of people who have Transitional Cell Carcinoma and experienced Cognitive Disorder *:

Common co-existing conditions for these people *:

Acute Hepatic Failure: 4 people, 26.67%
Agitation (state of anxiety or nervous excitement): 4 people, 26.67%
Diarrhea: 4 people, 26.67%
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 4 people, 26.67%
Pneumonia: 4 people, 26.67%
Febrile Neutropenia (fever with reduced white blood cells): 4 people, 26.67%
Vena Cava Embolism (obstruction of large vein carrying deoxygenated blood into the heart): 4 people, 26.67%
Hyperglycemia (high blood sugar): 4 people, 26.67%
Insomnia (sleeplessness): 3 people, 20.00%
High Blood Cholesterol: 2 people, 13.33%

Common drugs taken by these people *:

Meropenem: 4 people, 26.67%
Ceftriaxone Sodium: 4 people, 26.67%
Ursodiol: 4 people, 26.67%
Dexmedetomidine Hydrochloride: 4 people, 26.67%
Fentanyl: 4 people, 26.67%
Solu-Cortef: 4 people, 26.67%
Keytruda: 4 people, 26.67%
Xarelto: 4 people, 26.67%
Alprazolam: 2 people, 13.33%
Compazine: 2 people, 13.33%

Common symptoms for these people *:

Diarrhea: 6 people, 40.00%
Febrile Neutropenia (fever with reduced white blood cells): 4 people, 26.67%
Agitation (state of anxiety or nervous excitement): 4 people, 26.67%
Hyperglycemia (high blood sugar): 4 people, 26.67%
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 4 people, 26.67%
Pneumonia: 4 people, 26.67%
Acute Hepatic Failure: 4 people, 26.67%
Vena Cava Embolism (obstruction of large vein carrying deoxygenated blood into the heart): 4 people, 26.67%
Drug-Induced Liver Injury (diseases of the liver that are caused by physician-prescribed medications): 3 people, 20.00%
Fall: 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Cognitive disorder?

- Check whether Cognitive disorder is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Transitional cell carcinoma (10,157 reports)
Cognitive disorder (56,151 reports)

All the drugs that are associated with Cognitive disorder:

Cognitive disorder (1,657 drugs)

All the conditions that are associated with Cognitive disorder:

Cognitive disorder (1,727 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Cognitive disorder and Transitional cell carcinoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.